We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
-24.42%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$4.95B
AUM Growth
-$3.47B
Cap. Flow
+$352M
Cap. Flow %
7.11%
Top 10 Hldgs %
77.21%
Holding
70
New
7
Increased
1
Reduced
6
Closed
12

Top Buys

Rank Stock Value
1
IONQ icon
IonQ
IONQ
+$487M
2
NET icon
Cloudflare
NET
+$166M
3
BZFD icon
BuzzFeed
BZFD
+$135M
4
UTRS
Minerva Surgical, Inc. Common Stock
UTRS
+$71.1M
5
NN icon
NextNav
NN
+$70.1M

Top Sells

Rank Stock Value
1
BILL icon
BILL Holdings
BILL
+$140M
2
HOOD icon
Robinhood
HOOD
+$103M
3
TRIL
Trillium Therapeutics Inc.
TRIL
+$101M
4
VECT
VectivBio Holding AG Ordinary Shares
VECT
+$51.8M
5
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$49.8M

Sector Composition

Rank Sector Weight
1 Healthcare 41.06%
2 Financials 26.07%
3 Technology 16.75%
4 Consumer Staples 7.84%
5 Industrials 5.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UP icon
51
Wheels Up
UP
$196M
$4.92M 0.1%
+5,306
New +$6.19M
TRVI icon
52
Trevi Therapeutics
TRVI
$2.58B
$4.63M 0.09%
5,940,796
– –
LUMO
53
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$2.61M 0.05%
376,916
-149,747
-28% -$1.26M
RGLS
54
DELISTED
Regulus Therapeutics
RGLS
$2.06M 0.04%
645,106
– –
TCON
55
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$960K 0.02%
17,336
– –
AKTX
56
Akari Therapeutics
AKTX
$13M
$678K 0.01%
565
– –
TPST icon
57
Tempest Therapeutics
TPST
$14.6M
$622K 0.01%
9,060
– –
ADXN
58
Addex Therapeutics
ADXN
$7.34M
$205K ﹤0.01%
9,000
– –
ARDX icon
59
Ardelyx
ARDX
$996M
– –
-13,633,582
Closed -$18M
BE icon
60
Bloom Energy
BE
$63.3B
– –
-1,333,333
Closed -$25M
LQDA icon
61
Liquidia Corp
LQDA
$7.95B
– –
-2,486,062
Closed -$6.86M
XENE icon
62
Xenon Pharmaceuticals
XENE
$6.09B
– –
-992,107
Closed -$15.2M
VIRX
63
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
– –
-37,093
Closed -$297K
GRTX
64
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
– –
-4,362,986
Closed -$35.3M
TRVN
65
DELISTED
Trevena, Inc.
TRVN
– –
-6,099
Closed -$4.69M
PHXM
66
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
– –
-62,500
Closed -$3.61M
VECT
67
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
– –
-67,069
Closed -$51.8M
MTCR
68
DELISTED
Metacrine, Inc. Common Stock
MTCR
– –
-3,062,977
Closed -$10.5M
TRIL
69
DELISTED
Trillium Therapeutics Inc.
TRIL
– –
-5,736,363
Closed -$101M
SBBP
70
DELISTED
Strongbridge Biopharma plc.
SBBP
– –
-4,141,308
Closed -$8.45M
1 2
3

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
GD
Grandfield & Dodd New York $1.77B AUM 23.43% 1-Year Est. Return
DF
DNCA Finance Paris, France $1.75B AUM 38.18% 1-Year Est. Return
HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

NEA Management Company's Q4 2021 Portfolio in Review

As of Q4 2021, NEA Management Company held 70 positions worth $4.95B, down 41% from $8.42B the previous quarter. Its ten largest holdings account for 77% of the portfolio.

NEA Management Company deployed $352M of net new capital in Q4 2021, opening 7 new positions and adding to 1 existing holding. Its largest new stake was IonQ: 29,229,659 shares worth $488M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 48% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was BILL Holdings, an estimated $140M trimmed.

  • NEA Management Company's largest Q4 2021 buy was IonQ: 29,229,659 shares worth $488M.
  • NEA Management Company added most to Cloudflare in Q4 2021, an estimated $166M increase.
  • NEA Management Company's biggest Q4 2021 reduction was BILL Holdings, cutting an estimated $140M.
  • NEA Management Company fully exited Trillium Therapeutics Inc. in Q4 2021, selling an estimated $101M.
  • NEA Management Company's ten largest holdings make up 77% of its $4.95B portfolio in Q4 2021.
  • NEA Management Company opened 7 new positions and closed 12 in Q4 2021.
  • NEA Management Company's portfolio value fell 41% quarter-over-quarter to $4.95B.

Based on NEA Management Company's 13F filing for Q4 2021, filed 14 Feb 2022.